Publication Type: | Journal Article |
Year of Publication: | 2022 |
Authors: | M. Sunder |
Journal: | American Family Physician |
Volume: | 106 |
Issue: | 1 |
Pagination: | 91-92 |
Date Published: | July 2022 |
Abstract: | Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for the treatment of head lice infestation in patients six months and older |
URL: | https://www.aafp.org/pubs/afp/issues/2022/0700/steps-abametapir-head-lice.html |
Taxonomic name: